<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Epidemiology and Public Health</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/05A30B83-B7B4-4010-AF9C-51C961A4808A"><gtr:id>05A30B83-B7B4-4010-AF9C-51C961A4808A</gtr:id><gtr:firstName>Douglas</gtr:firstName><gtr:otherNames>Graham</gtr:otherNames><gtr:surname>Altman</gtr:surname><gtr:orcidId>0000-0002-7183-4083</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/144FF201-C516-40D8-9E86-092C9CFFFFE6"><gtr:id>144FF201-C516-40D8-9E86-092C9CFFFFE6</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Croft</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D1E23119-6069-455D-ACE9-A90B556A0D6C"><gtr:id>D1E23119-6069-455D-ACE9-A90B556A0D6C</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:otherNames>Gray</gtr:otherNames><gtr:surname>Roberts</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5DABC140-76D1-49D2-BDB6-0366C03E390E"><gtr:id>5DABC140-76D1-49D2-BDB6-0366C03E390E</gtr:id><gtr:firstName>Aroon</gtr:firstName><gtr:otherNames>Dinesh</gtr:otherNames><gtr:surname>Hingorani</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9D4ED459-1A3C-4EDD-8EFD-AECE9355C90A"><gtr:id>9D4ED459-1A3C-4EDD-8EFD-AECE9355C90A</gtr:id><gtr:firstName>Adam</gtr:firstName><gtr:surname>Timmis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/01A2B752-F82F-4F2F-B246-458D6E5D872D"><gtr:id>01A2B752-F82F-4F2F-B246-458D6E5D872D</gtr:id><gtr:firstName>Harry</gtr:firstName><gtr:surname>Hemingway</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/25A09599-6517-4900-9948-924DBF06C145"><gtr:id>25A09599-6517-4900-9948-924DBF06C145</gtr:id><gtr:firstName>Pablo</gtr:firstName><gtr:surname>Perel</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/93AFAB1F-230C-4C8A-AA50-38663891EE93"><gtr:id>93AFAB1F-230C-4C8A-AA50-38663891EE93</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Riley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FAEC3976-C7AE-487D-B1D2-610AB215700C"><gtr:id>FAEC3976-C7AE-487D-B1D2-610AB215700C</gtr:id><gtr:firstName>Dani?lle</gtr:firstName><gtr:surname>van der Windt</gtr:surname><gtr:orcidId>0000-0002-7248-6703</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902393"><gtr:id>7FE5351C-1320-4C70-8311-DD34930852B7</gtr:id><gtr:title>Prognosis Research: A Strategic Initiative in Translational Pathways (PROGRESS)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0902393</gtr:grantReference><gtr:abstractText>Strategic importance A basic form of clinical enquiry involves characterising people with disease or illness at one time point and following them up to see whether and why they have progressed at another time point. Such prognosis research is important in understanding how to ?translate? new approaches to improving health from initial discovery, through phases of evaluation and, where appropriate, into clinical practice. Prognosis research should complement and add value to MRC strategic aims, relating to: genetics, biomarkers, wellbeing, exploitation of health records and population based data and translational research. 

But numerous systematic reviews across different disease areas suggest that there is a gap between the promise of prognosis research and its ability to deliver. As a response to this we have developed a forthcoming series of 6 articles in BMJ/PloSMed which sets out a framework of prognosis research and makes recommendations. 

Aim: The aim of the PROGRESS Partnership is to critically develop and systematically apply concepts, methods and recommendations (from the initial PROGRESS article series and elsewhere) across different disease areas in order to enhance the translational impact of prognosis research. 

Partnership We will achieve this aim by establishing a new international consortium in translational prognosis research. Investigators in the Partnership (drawn from authors of the 6 article series) lead current prognosis research funding of #66 million. With MRC support the international Partnership will be established across disease areas and methodological disciplines. 

Partnership workstreams The Partnership will deliver three inter-related, milestone-driven workstreams: I Enabling activities, through targeted workshops we seek to (a) advance methods development in stratified medicine, which seeks to target treatments at those patients who will benefit the most (b) improve the openness (?transparency?) with which prognosis research is reported in scientific papers, (c) identify opportunities for better research across clinical cohorts and (d) disseminate Partnership findings (knowledge transfer). II New research We will do new research, focussing on examples of where prognosis research is important in translation across our Partnership. We will both look backwards at published literature (knowledge synthesis) and forwards carrying out new analyses in our own clinical cohorts. These include novel opportunities in over 50,000 patients with different diseases: coronary disease; cancer, acute severe bleeding in trauma and childbirth and musculoskeletal disorders. III Training We will develop a range of taught course, higher degree and Fellowship opportunities to develop future national and international leaders in prognosis research.</gtr:abstractText><gtr:technicalSummary>Strategic importance Prognosis research should be a basic science for translational research, clinical practice, personalised medicine and, with increasing periods of the lifecourse lived with chronic disease, for public health. Prognosis research should complement and add value to MRC strategic aims, principally those relating to: genetics, biomarkers, wellbeing, translational research and exploitation of health records and population based data. 

But numerous systematic reviews across different disease areas suggest that there is a gap between the promise of prognosis research and its ability to deliver. Internationally there have been no initiatives bringing together prognosis research across early and late stages in translation, across different prognosis research questions, and across disease areas. In short, the field is fragmented. As a response to this we have developed a forthcoming series of 6 articles in BMJ/PloSMed which sets out a framework of prognosis research and makes recommendations. 

Aim: The aim of the PROGRESS Partnership is to critically develop and systematically apply concepts, methods and recommendations (from the initial PROGRESS article series and elsewhere) across different disease areas in order to enhance the translational impact of prognosis research. 
 
Partnership We will achieve this aim by establishing a new international consortium in translational prognosis research. Investigators in the Partnership (drawn from authors of the 6 article series) lead current prognosis research funding of #66m. With MRC support we will galvanise these resources with a Partnership across disease areas (cardiovascular, cancer, musculoskeletal, trauma and emergency medicine) and methodological disciplines (biostatistics, epidemiology, genetics, biomarkers, health services research).
 
Partnership workstreams The Partnership will break new ground in delivering three inter-related, milestone-driven workstreams: I Enabling and underpinning activities, through targeted workshops we will advance methods development in stratified medicine, ?transparency? standards in prognostic models, strategic direction across new and existing prognostic cohorts and knowledge transfer. II New research on translational exemplars involving new knowledge syntheses in stratified medicine (field synopses and high resolution systematic reviews), and new prospective analyses in our Partnership cohorts and trials. We will exploit novel opportunities in coronary disease (cohort with DNA and deep phenotyping n=5000); cancer (new translational DNA, plasma and tissue bioresource cohort of head and neck cancer patients, n=5000), acute severe haemorrhage trials in trauma (n=20,000), post-partum haemorrhage (n=15,000); musculoskeletal disorders n=7000 patients with repeat measures over 7 years. III boosting capability through training developing future national and international leaders in prognosis research through taught courses, PhD studentships, and Fellowships.</gtr:technicalSummary><gtr:fund><gtr:end>2016-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>809397</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Public Health, Epidemiology &amp; Biostatistics (PHEB)</gtr:department><gtr:description>PROGRESS Partnership</gtr:description><gtr:id>736AF4E5-8F7E-450F-B221-4335E1FD8804</gtr:id><gtr:impact>MRC grant G0902393
16 manuscripts published 
2 International three-day courses (PROGRESS Summer Course in Prognosis Research 2013 &amp;amp; 2014)
Several workshops about prognosis research, use of longitudinal data, clinical cohorts, Stratified Medicine, diagnosis versus prognosis
Monthly teleconferences for discussing ideas and 3 overall PROGRESS Research meetings so far (last one Oct 2014 at Farr Institute, London)</gtr:impact><gtr:outcomeId>X8d8y7RsxQT-4</gtr:outcomeId><gtr:partnerContribution>Our partners have contributed in all areas of this partnership including writing and preparation of the core papers and research exemplars, promoting the the PROGRESS framework in various meetings and research collaborations, writing grants (both methodological and translational), and organising and presenting in workshops and short courses that we developed.</gtr:partnerContribution><gtr:piContribution>We developed a series of articles which sets out a framework of prognosis research and makes recommendations. Apart from these core papers, we have promoted the PROGRESS framework of prognosis research in several auxiliary papers and research exemplars from our ongoing population research. We have collaborated with other partner for writing grants, and currently plan to apply for an MRC Methodology research programme grant to continue our collaborations for developing new methods in the prognosis research area. We have also organised several workshops and short courses and presented our partnership in various international meetings and collaborations.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Statistics in Medicine</gtr:department><gtr:description>PROGRESS Partnership</gtr:description><gtr:id>35BFA009-228A-4400-8C9D-29B5D02CC0D3</gtr:id><gtr:impact>MRC grant G0902393
16 manuscripts published 
2 International three-day courses (PROGRESS Summer Course in Prognosis Research 2013 &amp;amp; 2014)
Several workshops about prognosis research, use of longitudinal data, clinical cohorts, Stratified Medicine, diagnosis versus prognosis
Monthly teleconferences for discussing ideas and 3 overall PROGRESS Research meetings so far (last one Oct 2014 at Farr Institute, London)</gtr:impact><gtr:outcomeId>X8d8y7RsxQT-2</gtr:outcomeId><gtr:partnerContribution>Our partners have contributed in all areas of this partnership including writing and preparation of the core papers and research exemplars, promoting the the PROGRESS framework in various meetings and research collaborations, writing grants (both methodological and translational), and organising and presenting in workshops and short courses that we developed.</gtr:partnerContribution><gtr:piContribution>We developed a series of articles which sets out a framework of prognosis research and makes recommendations. Apart from these core papers, we have promoted the PROGRESS framework of prognosis research in several auxiliary papers and research exemplars from our ongoing population research. We have collaborated with other partner for writing grants, and currently plan to apply for an MRC Methodology research programme grant to continue our collaborations for developing new methods in the prognosis research area. We have also organised several workshops and short courses and presented our partnership in various international meetings and collaborations.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Epidemiology and Population Health</gtr:department><gtr:description>PROGRESS Partnership</gtr:description><gtr:id>21FD64AE-2352-4701-A37F-176E9B0E7F78</gtr:id><gtr:impact>MRC grant G0902393
16 manuscripts published 
2 International three-day courses (PROGRESS Summer Course in Prognosis Research 2013 &amp;amp; 2014)
Several workshops about prognosis research, use of longitudinal data, clinical cohorts, Stratified Medicine, diagnosis versus prognosis
Monthly teleconferences for discussing ideas and 3 overall PROGRESS Research meetings so far (last one Oct 2014 at Farr Institute, London)</gtr:impact><gtr:outcomeId>X8d8y7RsxQT-5</gtr:outcomeId><gtr:partnerContribution>Our partners have contributed in all areas of this partnership including writing and preparation of the core papers and research exemplars, promoting the the PROGRESS framework in various meetings and research collaborations, writing grants (both methodological and translational), and organising and presenting in workshops and short courses that we developed.</gtr:partnerContribution><gtr:piContribution>We developed a series of articles which sets out a framework of prognosis research and makes recommendations. Apart from these core papers, we have promoted the PROGRESS framework of prognosis research in several auxiliary papers and research exemplars from our ongoing population research. We have collaborated with other partner for writing grants, and currently plan to apply for an MRC Methodology research programme grant to continue our collaborations for developing new methods in the prognosis research area. We have also organised several workshops and short courses and presented our partnership in various international meetings and collaborations.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Keele University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Research Institute for Primary Care and Health Sciences</gtr:department><gtr:description>PROGRESS Partnership</gtr:description><gtr:id>FC2572E5-8219-4E0A-B269-A7EE2050087E</gtr:id><gtr:impact>MRC grant G0902393
16 manuscripts published 
2 International three-day courses (PROGRESS Summer Course in Prognosis Research 2013 &amp;amp; 2014)
Several workshops about prognosis research, use of longitudinal data, clinical cohorts, Stratified Medicine, diagnosis versus prognosis
Monthly teleconferences for discussing ideas and 3 overall PROGRESS Research meetings so far (last one Oct 2014 at Farr Institute, London)</gtr:impact><gtr:outcomeId>X8d8y7RsxQT-3</gtr:outcomeId><gtr:partnerContribution>Our partners have contributed in all areas of this partnership including writing and preparation of the core papers and research exemplars, promoting the the PROGRESS framework in various meetings and research collaborations, writing grants (both methodological and translational), and organising and presenting in workshops and short courses that we developed.</gtr:partnerContribution><gtr:piContribution>We developed a series of articles which sets out a framework of prognosis research and makes recommendations. Apart from these core papers, we have promoted the PROGRESS framework of prognosis research in several auxiliary papers and research exemplars from our ongoing population research. We have collaborated with other partner for writing grants, and currently plan to apply for an MRC Methodology research programme grant to continue our collaborations for developing new methods in the prognosis research area. We have also organised several workshops and short courses and presented our partnership in various international meetings and collaborations.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Research Department of Epidemiology and Public Health</gtr:department><gtr:description>PROGRESS Partnership</gtr:description><gtr:id>D2512497-DA96-4A4D-9364-B92FBACA2CC4</gtr:id><gtr:impact>MRC grant G0902393
16 manuscripts published 
2 International three-day courses (PROGRESS Summer Course in Prognosis Research 2013 &amp;amp; 2014)
Several workshops about prognosis research, use of longitudinal data, clinical cohorts, Stratified Medicine, diagnosis versus prognosis
Monthly teleconferences for discussing ideas and 3 overall PROGRESS Research meetings so far (last one Oct 2014 at Farr Institute, London)</gtr:impact><gtr:outcomeId>X8d8y7RsxQT-1</gtr:outcomeId><gtr:partnerContribution>Our partners have contributed in all areas of this partnership including writing and preparation of the core papers and research exemplars, promoting the the PROGRESS framework in various meetings and research collaborations, writing grants (both methodological and translational), and organising and presenting in workshops and short courses that we developed.</gtr:partnerContribution><gtr:piContribution>We developed a series of articles which sets out a framework of prognosis research and makes recommendations. Apart from these core papers, we have promoted the PROGRESS framework of prognosis research in several auxiliary papers and research exemplars from our ongoing population research. We have collaborated with other partner for writing grants, and currently plan to apply for an MRC Methodology research programme grant to continue our collaborations for developing new methods in the prognosis research area. We have also organised several workshops and short courses and presented our partnership in various international meetings and collaborations.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>PROGRESS Partnership</gtr:description><gtr:id>9C0CD18F-6684-4D5B-8F58-C0F52865C158</gtr:id><gtr:impact>MRC grant G0902393
16 manuscripts published 
2 International three-day courses (PROGRESS Summer Course in Prognosis Research 2013 &amp;amp; 2014)
Several workshops about prognosis research, use of longitudinal data, clinical cohorts, Stratified Medicine, diagnosis versus prognosis
Monthly teleconferences for discussing ideas and 3 overall PROGRESS Research meetings so far (last one Oct 2014 at Farr Institute, London)</gtr:impact><gtr:outcomeId>X8d8y7RsxQT-6</gtr:outcomeId><gtr:partnerContribution>Our partners have contributed in all areas of this partnership including writing and preparation of the core papers and research exemplars, promoting the the PROGRESS framework in various meetings and research collaborations, writing grants (both methodological and translational), and organising and presenting in workshops and short courses that we developed.</gtr:partnerContribution><gtr:piContribution>We developed a series of articles which sets out a framework of prognosis research and makes recommendations. Apart from these core papers, we have promoted the PROGRESS framework of prognosis research in several auxiliary papers and research exemplars from our ongoing population research. We have collaborated with other partner for writing grants, and currently plan to apply for an MRC Methodology research programme grant to continue our collaborations for developing new methods in the prognosis research area. We have also organised several workshops and short courses and presented our partnership in various international meetings and collaborations.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>77D95C8C-04C6-452B-BE71-E30493EB4575</gtr:id><gtr:title>Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b19ed23372dae5b7a38361522a0300cc"><gtr:id>b19ed23372dae5b7a38361522a0300cc</gtr:id><gtr:otherNames>Snell KI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>56deca3e641694.63058963</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F1F878E-2464-4B76-831B-4B3C7BE2D8A6</gtr:id><gtr:title>Prognosis research strategy (PROGRESS) 4: stratified medicine research.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f87a3660179f7a26dfc636854e4fec8"><gtr:id>1f87a3660179f7a26dfc636854e4fec8</gtr:id><gtr:otherNames>Hingorani AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>doi_55f98598555a2c50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>265A777D-3928-4192-B950-054AF54CBD9C</gtr:id><gtr:title>Adequate sample size for developing prediction models is not simply related to events per variable.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74fa035ca46750ca6fe32765f3d09428"><gtr:id>74fa035ca46750ca6fe32765f3d09428</gtr:id><gtr:otherNames>Ogundimu EO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>585d68f221c655.24612010</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5218F4E3-BA1E-43AD-A7CA-6FD3A47D1CF7</gtr:id><gtr:title>Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD).</gtr:title><gtr:parentPublicationTitle>Annals of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d0b6631c58a87bced6b9125d9f5c0a8"><gtr:id>9d0b6631c58a87bced6b9125d9f5c0a8</gtr:id><gtr:otherNames>Collins GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-4819</gtr:issn><gtr:outcomeId>56dec65285e124.43555291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8179AD6C-98F4-4ABA-B123-FED90FDE85D0</gtr:id><gtr:title>Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b58ca594e9e3476ff0348cb7f6658926"><gtr:id>b58ca594e9e3476ff0348cb7f6658926</gtr:id><gtr:otherNames>Pujades-Rodriguez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>56cc4577e6aff7.53793192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB9F56EC-729F-41C7-81DB-FC2FBABBB9FC</gtr:id><gtr:title>The science of clinical practice: disease diagnosis or patient prognosis? Evidence about &amp;quot;what is likely to happen&amp;quot; should shape clinical practice.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de96b25fd01c1069bc85b0d5891fb15d"><gtr:id>de96b25fd01c1069bc85b0d5891fb15d</gtr:id><gtr:otherNames>Croft P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>doi_55f9859855634729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A89F8C1A-6921-4B91-8222-0342DF39AB89</gtr:id><gtr:title>Improving the transparency of prognosis research: the role of reporting, data sharing, registration, and protocols.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ace24269b18fe28999cf31261b593d3"><gtr:id>8ace24269b18fe28999cf31261b593d3</gtr:id><gtr:otherNames>Peat G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>pm_540e170e170932cc2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D889A3A1-60FE-478C-BE48-0283C5825A10</gtr:id><gtr:title>Red blood cell transfusion and mortality in trauma patients: risk-stratified analysis of an observational study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfd8c267b78cf5a764bc4ee22e4f0a1e"><gtr:id>cfd8c267b78cf5a764bc4ee22e4f0a1e</gtr:id><gtr:otherNames>Perel P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>546485c7acd997.25770856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15274762-136F-4257-B8EB-CB607E8AFDF3</gtr:id><gtr:title>Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bb45c4c7a5bcec753842366297e3e48"><gtr:id>3bb45c4c7a5bcec753842366297e3e48</gtr:id><gtr:otherNames>Hemingway H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>bj32DcL9RcZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16F3DD3D-F1BA-45FD-B555-1984247E0425</gtr:id><gtr:title>Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1&amp;middot;9 million people.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1d80c3159b9d9692bb3652348af076"><gtr:id>bb1d80c3159b9d9692bb3652348af076</gtr:id><gtr:otherNames>Shah AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>56cc4a45dbb116.46724896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEA24C0D-595D-44EA-90FD-22F9D0948C91</gtr:id><gtr:title>Socioeconomic deprivation and the incidence of 12 cardiovascular diseases in 1.9 million women and men: implications for risk prediction and prevention.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b58ca594e9e3476ff0348cb7f6658926"><gtr:id>b58ca594e9e3476ff0348cb7f6658926</gtr:id><gtr:otherNames>Pujades-Rodriguez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5475c06a57d307.11518052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBA12403-BD82-4D4F-B6E7-5656723B6A5D</gtr:id><gtr:title>Does a modified STarT Back Tool predict outcome with a broader group of musculoskeletal patients than back pain? A secondary analysis of cohort data.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7dae36e9dbe70965770074d2eebc2a7"><gtr:id>c7dae36e9dbe70965770074d2eebc2a7</gtr:id><gtr:otherNames>Hill JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>585d3b13ba6a96.45143661</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33643B6E-1313-45D9-B31D-EE9923052FA4</gtr:id><gtr:title>Individual participant data (IPD) meta-analyses of diagnostic and prognostic modeling studies: guidance on their use.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76c9d1b02ecba3fca9a1898d6c28cfd4"><gtr:id>76c9d1b02ecba3fca9a1898d6c28cfd4</gtr:id><gtr:otherNames>Debray TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>56dec9848a5a38.01572611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D9263EC-CFED-41E6-B321-61496487FA91</gtr:id><gtr:title>Development of hand phenotypes and changes in hand pain and problems over time in older people.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7eded4bb45e93ff97524a7391651d7dd"><gtr:id>7eded4bb45e93ff97524a7391651d7dd</gtr:id><gtr:otherNames>Green DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>56dec76596a780.37363166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6A250CE-0425-42D2-BA2D-8F5E334A09C1</gtr:id><gtr:title>Sample size considerations for the external validation of a multivariable prognostic model: a resampling study.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d0b6631c58a87bced6b9125d9f5c0a8"><gtr:id>9d0b6631c58a87bced6b9125d9f5c0a8</gtr:id><gtr:otherNames>Collins GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>56dee39826fe94.54271599</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F1E3EC1-6682-4FCC-8667-71BEF44348DA</gtr:id><gtr:title>Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1&amp;middot;25 million people.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f620fe51d4a8878fc48d55995253fe2f"><gtr:id>f620fe51d4a8878fc48d55995253fe2f</gtr:id><gtr:otherNames>Rapsomaniki E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5464866c2b43b6.70260346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>658F3626-A96C-4562-8324-3FE29699D669</gtr:id><gtr:title>External validation of multivariable prediction models: a systematic review of methodological conduct and reporting.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d0b6631c58a87bced6b9125d9f5c0a8"><gtr:id>9d0b6631c58a87bced6b9125d9f5c0a8</gtr:id><gtr:otherNames>Collins GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn><gtr:outcomeId>56dee49bee2846.78005496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>506B783E-9A11-4BD8-804C-3ADE431E8121</gtr:id><gtr:title>Predicting early death in patients with traumatic bleeding: development and validation of prognostic model.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfd8c267b78cf5a764bc4ee22e4f0a1e"><gtr:id>cfd8c267b78cf5a764bc4ee22e4f0a1e</gtr:id><gtr:otherNames>Perel P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>doi_14224__bmj_e5166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F07F3785-8874-473C-BDDD-50F5916A3397</gtr:id><gtr:title>Defining disease phenotypes using national linked electronic health records: a case study of atrial fibrillation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be1700d700d28c82127f9153b743f95e"><gtr:id>be1700d700d28c82127f9153b743f95e</gtr:id><gtr:otherNames>Morley KI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>546485217bd719.66829721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB36E311-767D-4610-9A0F-22BC89BEE12B</gtr:id><gtr:title>Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c52e4deee667ee3268bc63509ddb9a85"><gtr:id>c52e4deee667ee3268bc63509ddb9a85</gtr:id><gtr:otherNames>Pasea L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>5a8ab4e328bb67.99573225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91962F0F-B379-4F32-BE04-92E28B6CCEBF</gtr:id><gtr:title>Multilevel mixed effects parametric survival models using adaptive Gauss-Hermite quadrature with application to recurrent events and individual participant data meta-analysis.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2057c985c76e13f0f2f14ab5e43ad32f"><gtr:id>2057c985c76e13f0f2f14ab5e43ad32f</gtr:id><gtr:otherNames>Crowther MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>doi_55f9859855479e7b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FC73770-E65A-491C-B788-A928518A0280</gtr:id><gtr:title>Assessing bias in studies of prognostic factors.</gtr:title><gtr:parentPublicationTitle>Annals of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8924b478a440d7186591516b0ec9225f"><gtr:id>8924b478a440d7186591516b0ec9225f</gtr:id><gtr:otherNames>Hayden JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0003-4819</gtr:issn><gtr:outcomeId>pm_14224_24_23420236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6651D586-C3C1-4C33-827B-CDEC7064B3AC</gtr:id><gtr:title>Brief pain re-assessment provided more accurate prognosis than baseline information for low-back or shoulder pain.</gtr:title><gtr:parentPublicationTitle>BMC musculoskeletal disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd018a1c5655545d8aa02d5129065cd5"><gtr:id>fd018a1c5655545d8aa02d5129065cd5</gtr:id><gtr:otherNames>Mansell G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2474</gtr:issn><gtr:outcomeId>5a6d9e0b18be11.10440710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68503E2C-6D72-46D1-B0B9-5FCF2EF92788</gtr:id><gtr:title>Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1937360 people in England: lifetime risks and implications for risk prediction.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b58ca594e9e3476ff0348cb7f6658926"><gtr:id>b58ca594e9e3476ff0348cb7f6658926</gtr:id><gtr:otherNames>Pujades-Rodriguez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>doi_55f9869867212f3d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A87B1349-A2A5-4F6D-BBF1-BA743552F2CA</gtr:id><gtr:title>External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>585d68f7bef1b5.41391172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4642936-7284-4B36-9AB4-8F43763A20A9</gtr:id><gtr:title>Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfd8c267b78cf5a764bc4ee22e4f0a1e"><gtr:id>cfd8c267b78cf5a764bc4ee22e4f0a1e</gtr:id><gtr:otherNames>Perel P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>54649e6f563f76.57930041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>804DC05A-9D2C-475C-8339-36B1F79C34A9</gtr:id><gtr:title>Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b244db03523acfcca3e96a5f37df371"><gtr:id>8b244db03523acfcca3e96a5f37df371</gtr:id><gtr:otherNames>Roberts I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>doi_14224__bmj_e5839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5657DD3-DA76-45A6-ADD6-3A7106BEF9D5</gtr:id><gtr:title>Using electronic health records to predict costs and outcomes in stable coronary artery disease.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4537906016f357c42a267a7bfa313a67"><gtr:id>4537906016f357c42a267a7bfa313a67</gtr:id><gtr:otherNames>Asaria M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>56cb38e2c0dc16.20166329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>899DBD68-C13F-4B5F-ABB8-5F1CD68431F5</gtr:id><gtr:title>Prognosis research ideally should measure time-varying predictors at their intended moment of use</gtr:title><gtr:parentPublicationTitle>Diagnostic and Prognostic Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4e4f53297a7f6314c488a923846c43a"><gtr:id>a4e4f53297a7f6314c488a923846c43a</gtr:id><gtr:otherNames>Whittle R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a2fd5b22c3826.04004231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>168C102C-A023-443C-869B-73988BDFC1D7</gtr:id><gtr:title>Does attrition during follow-up of a population cohort study inevitably lead to biased estimates of health status?</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f23bdeb14e9a015c56a9c2c23f16fec1"><gtr:id>f23bdeb14e9a015c56a9c2c23f16fec1</gtr:id><gtr:otherNames>Lacey RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>546493637544d1.21568655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4033B1C9-AB31-4B2F-944F-6363E8C39138</gtr:id><gtr:title>Comparison of random forest and parametric imputation models for imputing missing data using MICE: a CALIBER study.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1d80c3159b9d9692bb3652348af076"><gtr:id>bb1d80c3159b9d9692bb3652348af076</gtr:id><gtr:otherNames>Shah AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>pm_540e170e17087fa57</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54A884D6-4937-401B-92D3-6E831D424AED</gtr:id><gtr:title>Multivariate meta-analysis of prognostic factor studies with multiple cut-points and/or methods of measurement.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>5675e376c1046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5DEE718-D5D2-4DD8-ABD1-297EA2872598</gtr:id><gtr:title>CYP2D6 genotype and tamoxifen response for breast cancer: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/021ffb5ed6d319ce5db4ef42f862f0a5"><gtr:id>021ffb5ed6d319ce5db4ef42f862f0a5</gtr:id><gtr:otherNames>Lum DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_14224_ne_0076648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15E8168D-6A5B-4519-BC2A-3284D4F3A386</gtr:id><gtr:title>Clinical Course and Prognostic Factors in Conservatively Managed Carpal Tunnel Syndrome: A&amp;nbsp;Systematic Review.</gtr:title><gtr:parentPublicationTitle>Archives of physical medicine and rehabilitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e777848cd5abe32ff0ae90bcedd111e"><gtr:id>9e777848cd5abe32ff0ae90bcedd111e</gtr:id><gtr:otherNames>Burton CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-9993</gtr:issn><gtr:outcomeId>56dec6e5c43e40.62455945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DD50427-A614-4A5F-81A1-8F47BC9FE7E5</gtr:id><gtr:title>Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.</gtr:title><gtr:parentPublicationTitle>Annals of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea46aa157f53303836291b13e8e0a302"><gtr:id>ea46aa157f53303836291b13e8e0a302</gtr:id><gtr:otherNames>Moons KG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-4819</gtr:issn><gtr:outcomeId>56dee405797d26.40097626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00F062F3-9615-469A-97EA-57285671A05E</gtr:id><gtr:title>Evaluation of Machine Learning Methods to Predict Coronary Artery Disease Using Metabolomic Data.</gtr:title><gtr:parentPublicationTitle>Studies in health technology and informatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee93f005eea352eaf4a6c3894d3b56d7"><gtr:id>ee93f005eea352eaf4a6c3894d3b56d7</gtr:id><gtr:otherNames>Forssen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0926-9630</gtr:issn><gtr:outcomeId>5a8ab71103fb56.98604741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC19FCC0-A301-43EE-9059-FA178ADB5D10</gtr:id><gtr:title>New Guideline for the Reporting of Studies Developing, Validating, or Updating a Multivariable Clinical Prediction Model: The TRIPOD Statement.</gtr:title><gtr:parentPublicationTitle>Advances in anatomic pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea46aa157f53303836291b13e8e0a302"><gtr:id>ea46aa157f53303836291b13e8e0a302</gtr:id><gtr:otherNames>Moons KG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1072-4109</gtr:issn><gtr:outcomeId>56dee3cff1ee63.48870767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B1D6BB9-CF61-4FFE-B49D-A725BDDAE692</gtr:id><gtr:title>Prognosis Research Strategy (PROGRESS) 3: prognostic model research.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ac8b4180281042780bc59e5352f469e"><gtr:id>2ac8b4180281042780bc59e5352f469e</gtr:id><gtr:otherNames>Steyerberg EW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>ncv8fHWHgNq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43B6340E-F623-4C91-8C78-914260DA95A2</gtr:id><gtr:title>Reply: Neutrophil Count Is Associated With Risks of Cardiovascular Diseases.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb1d80c3159b9d9692bb3652348af076"><gtr:id>bb1d80c3159b9d9692bb3652348af076</gtr:id><gtr:otherNames>Shah AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn><gtr:outcomeId>5a8ab4a3677680.99874453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F4920E0-5BE1-432F-B3D8-A55B0BEDC1D1</gtr:id><gtr:title>A 10-year prognostic model for patients with suspected angina attending a chest pain clinic.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8df54dfa55b5c3682cea6b37f48d2dfd"><gtr:id>8df54dfa55b5c3682cea6b37f48d2dfd</gtr:id><gtr:otherNames>Sekhri N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn><gtr:outcomeId>56d5b49bd5b994.09421830</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5058E3F4-E224-4CB7-B5AC-2BAEC6BA1810</gtr:id><gtr:title>How Does Cardiovascular Disease First Present in Women and Men? Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1,937,360 People.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04612eb13fa31d0236e102d8529322f2"><gtr:id>04612eb13fa31d0236e102d8529322f2</gtr:id><gtr:otherNames>George J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>56cb3d3cecffa9.09371086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D461345-1BA2-4F19-9969-4168E9B3D9D8</gtr:id><gtr:title>Prognosis Research Strategy (PROGRESS) 2: prognostic factor research.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697c8bb8cb68a1c70016910abcad865a"><gtr:id>697c8bb8cb68a1c70016910abcad865a</gtr:id><gtr:otherNames>Riley RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>iTkLqsygE76</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A81023F9-CCF5-4962-9CA2-5D8A82331DBE</gtr:id><gtr:title>Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f620fe51d4a8878fc48d55995253fe2f"><gtr:id>f620fe51d4a8878fc48d55995253fe2f</gtr:id><gtr:otherNames>Rapsomaniki E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>pm_540e170e1706d7860</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902393</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>6393C0B5-F394-4AB6-9626-AD6D94C7BCB5</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Injuries and Accidents</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>B3B786B2-60C5-4A01-808F-859CEE871296</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>8.5  Resources and infrastructure (health services)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>